Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,862,276
-$7,378,746 QoQ
Shares Held
1,238,678
-56.3% QoQ
Ownership
0.621%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Derivatives in ANNX
reported options exposure · as of Jun 30, 2024CallValue
$245,000
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. ANNX ranks #146 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ANNX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,862,276 | 1,238,678 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,241,022 | 2,836,857 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,609,610 | 2,822,823 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,033,921 | 2,514,134 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $338,334 | 175,303 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $798,617 | 155,676 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $430,117 | 72,655 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $245,000 | 50,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $1,701,338 | 347,212 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,164,607 | 1,278,188 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $143,400 | 20,000 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $3,682,026 | 811,019 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $524,578 | 222,279 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,174,772 | 617,833 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,252,720 | 1,364,343 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,722,165 | 526,531 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,389,186 | 548,412 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,538,156 | 407,999 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,124,672 | 411,968 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,076,307 | 354,770 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $204,747 | 11,002 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||